Sanofi to Invest in Vaccine Production Site in Singapore
12 Abril 2021 - 12:54AM
Noticias Dow Jones
By Cecilia Butini
Sanofi SA said Monday that it would invest in a vaccine
production center in Singapore.
The French pharmaceutical major said it is planning to invest
400 million euros ($476.1 million) over five years, and that the
new site will allow it to produce vaccines on a massive scale for
Asia and to complement exisiting manufacturing capacity in Europe
and North America.
The project is expected to create up to 200 local jobs, the
company said.
Construction of the plant is expected to being in the third
quarter of 2021, with the site becoming fully operational in the
first quarter of 2026, Sanofi said.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
April 12, 2021 01:39 ET (05:39 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Sanofi (EU:SAN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Sanofi (EU:SAN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
